Elegen
4 known investors
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep Tech
Investors · 4
In the news
- Elegen Raises the Bar for Synthetic DNA by Lowering Prices Across Its ENFINIA™ Portfoliobusinesswire.com · 2026
- Revolutionizing Synthetic Biology: ELEGEN Secures $35M in Series B Funding | SignalBasetrysignalbase.com · 2024
- Elegen Raises $35M in Series B Funding to Advance DNA Synthesis - Woodgate Computerswoodgatecomputers.com · 2024
- Elegen Raises $35M in Series B Financing Round | GenomeWebgenomeweb.com · 2024
- Elegen Raises $35 Million in Series B to Accelerate Expansion into Clinical Manufacturingbusinesswire.com · 2024
- Elegen - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2021